Cellbricks

Cellbricks is a startup based in Germany. Its most recent tracked round is Seed. Brouky classifies it under Industry & Hardware. Brouky records 1 investor associated with the company.

Cellbricks develops a patented bioprinting process that enables manufacturing of in-vitro tissue models, personalized implants, and organ-replacement constructs by printing multiple cell types into tissue-like structures with integrated vascular systems.